Blood News and Research

RSS

Drug commonly used for diabetes might be effective in treating multiple sclerosis

Researchers at the University of Illinois at Chicago are launching a clinical trial to determine whether a drug commonly used for diabetes might be effective in treating multiple sclerosis, an autoimmune disease that affects 350,000 Americans.

10 Jun 2004

Survey finds over 60% of clinically obese women began dieting before 14

A University of California, Berkeley-led survey of women defined as clinically obese shows that nearly two-thirds of them went on their first diet before age 14 and, as adults, were more likely to be heavier than women who started dieting after age 14.

10 Jun 2004

Conflicting views on embryonic and adult stem cells complicate research in stem cell therapeutics

Though there has been considerable biological and political debate over the use of embryonic stem cells (ESCs) vs. adult stem cells (ASCs) as therapies for tissue engineering and organ transplants, inherent benefits and drawbacks in both techniques compel them to coexist and complement each other.

10 Jun 2004

Remicade shows improvement in both the arthritis and psoriasis associated with psoriatic arthritis

In this trial, REMICADE provided a 70 percent improvement (as measured by ACR 70) in symptoms of arthritis in nearly one-third of patients, compared with only 2 percent of patients on placebo at 24 weeks.

10 Jun 2004

Breath test device detects early symptoms of diabetes

John Plodinec and Chuji Wang already have developed a prototype and applied for a patent. They now are seeking a commercial partner to help them move their unique diabetes breath analyzer from the university laboratory into the marketplace.

10 Jun 2004

Higher-than-normal amounts of a selenium-containing enzyme could promote type 2 diabetes

A study by researchers at Cornell University suggests that higher-than-normal amounts of a selenium-containing enzyme could promote type 2 diabetes.

10 Jun 2004

Drug may benefit patients suffering deep scarring after radiation treatment

Cancer patients who suffer from a progressive, deep scarring of tissue following radiation treatment might benefit from a drug that’s FDA-approved to treat vascular disease, according to a University of Rochester study published in this month’s Journal of Clinical Oncology.

10 Jun 2004

Non-aspirin pain drugs may help men with recurrent prostate cancer

Early results from a University of North Carolina at Chapel Hill School of Medicine study may determine if drugs called Cox-2 inhibitors, a newer type of non-aspirin pain medicine now widely prescribed for arthritis symptoms, may benefit men with recurrent prostate cancer.

10 Jun 2004

Exercise and fish oil supplement dramatically decreases risk of atherosclerosis

Nearly one quarter of all Americans have some form of cardiovascular disease, according to the Centers for Disease Control, and each year about 950,000 Americans die of heart disease.

10 Jun 2004

FDA approval for miniature robot for spinal procedures

A miniature robot for fail-proof spinal procedures has received FDA approval. Named SpineAssist, the robot is the brainchild of Technion-Israel Institute of Technology Mechanical Engineering Professor Moshe Shoham.

10 Jun 2004

Some African American adolescents who live in cities have low levels of vitamin D

Some African American adolescents who live in cities have low levels of vitamin D, according to an article in the June issue of the Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.

9 Jun 2004

New blood test may help detect breast cancer

Researchers at UT Southwestern Medical Center at Dallas have developed a blood test that can detect amplification of a certain gene found in circulating cells associated with breast cancer.

9 Jun 2004

Untreated transient ischemic attacks put 21,000 Canadians at increased risk of death, stroke or heart attack

The Canadian Heart and Stroke Foundation warns that untreated transient ischemic attacks (TIAs) are putting nearly 21,000 Canadians at increased risk of death, stroke or heart attack.

9 Jun 2004

Genetic link between hormones and migraine

Director of the Genomics Research Centre Professor Lyn Griffiths and her team of researchers at Griffith University have identified a genetic link between hormones and migraine.

9 Jun 2004

Patent issued for GHB, date rape drug test

A patent for a highly sensitive test to detect the presence of the "date rape" drug, GHB, has recently been granted to the University of California, Santa Barbara.

9 Jun 2004

New statistical techniques for cancer diagnosis

CSIRO statisticians have developed a new way to subtype paediatric Acute Lymphoblastic Leukaemia (ALL), the most common form of cancer in children under 12.

9 Jun 2004

Foundation for poor heart health laid early in life

Heart disease - long viewed as a scourge of adulthood - is a growing threat to children because of soaring rates of obesity and related problems, such as diabetes.

9 Jun 2004

SU11248 proves effective in the treatment of gastrointestinal stromal tumors

A drug originally developed to block the formation of blood vessels in tumors has been shown to overcome resistance to treatment with Gleevec in patients with gastrointestinal stromal tumors (GIST).

9 Jun 2004

Lovastatin and Simvastatin have a significantly reduced risk of prostate cancer

Men who take even small amounts of common cholesterol-lowering drugs such as Lovastatin and Simvastatin have a significantly reduced risk of prostate cancer, according to a new study by Oregon Health & Science University Cancer Institute researchers.

9 Jun 2004

Discovery may help those susceptible to deep-vein thrombosis, strokes and recurrent miscarriages

Australian researchers at University of New South Wales have identified a mechanism than can cause blood clots - a discovery with implications for those susceptible to deep-vein thrombosis, strokes and recurrent miscarriages.

7 Jun 2004